|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/22/20 RTW Investments, LP SC 13D 2:124K Avidity Biosciences, Inc. M2 Compliance/FA |
Document/Exhibit Description Pages Size
1: SC 13D Statement of Acquisition of Beneficial Ownership HTML 50K
by a Non-Passive Investor
2: EX-2 Plan of Acquisition, Reorganization, Arrangement, HTML 9K
Liquidation or Succession
Exhibit 2
Joint Filing Statement
Pursuant to Rule 13d-1(k)(1)
The undersigned hereby consent and agree to the joint filing of Schedule 13D under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock of Avidity Biosciences, Inc. beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Joint Filing Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13D, thereby incorporating the same into such Schedule13D.
This Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.
Dated: June 22, 2020
| RTW INVESTMENTS, LP | ||
| By: | /s/ Roderick Wong | |
| Roderick Wong, M.D., Managing Partner | ||
| RTW MASTER FUND, LTD. | ||
| By: | /s/ Roderick Wong | |
| Roderick Wong, M.D., Director | ||
| RODERICK WONG | ||
| By: | /s/ Roderick Wong | |
| Roderick Wong, M.D., Individually | ||
C:
| This ‘SC 13D’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 6/22/20 | None on these Dates | ||
| List all Filings | ||||